| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/16/2014 | CN103724353A Improved synthesis method of penoxsulam |
| 04/16/2014 | CN103724352A Intermediate of DPP-IV (dipeptidyl peptidase IV) inhibitor, preparation method of intermediate and method for preparing DPP-IV inhibitor through intermediate |
| 04/16/2014 | CN103724351A Compound for treating cerebral palsy and use thereof |
| 04/16/2014 | CN103724350A Compound for treating cerebral palsy and use thereof |
| 04/16/2014 | CN103724349A Compound for treating cerebral palsy and use thereof |
| 04/16/2014 | CN103724322A Androgen receptor modulators and uses thereof |
| 04/16/2014 | CN103723864A Treatment process of ammonium chloride evaporative condensate |
| 04/16/2014 | CN102584836B Porphyrin cage compound, and preparation method and application thereof |
| 04/16/2014 | CN102216298B Imidazopyridines and imidazopyrimidines as HIV-1 reverse transcriptase inhibitors |
| 04/16/2014 | CN102066378B 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazine derivatives as MET kinase inhibitors |
| 04/16/2014 | CN101967148B Novel pyrazolo[1,5-a]pyrimidines compound for labeling 18F instead of p-benzenesulfonyloxy and preparation and application |
| 04/15/2014 | US8697910 Optically active quaternary ammonium salt having axial asymmetry and process for producing α-amino acid and derivative thereof with the same |
| 04/15/2014 | US8697742 BCRP/ABCG2 inhibitor |
| 04/15/2014 | US8697713 Pyrrolopyrimidines for pharmaceutical compositions |
| 04/15/2014 | US8697711 Inhibitors of bruton'S tyrosine kinase |
| 04/15/2014 | US8697710 Optionally substituted 3-amino-4-(thioxo or imino)-4,5-dihydro-2H-pyrazolo [3,4-d]pyrimidin-6(7H)-ones |
| 04/15/2014 | US8697708 Azabenzothiazole compounds, compositions and methods of use |
| 04/15/2014 | US8697698 Pyrazole compounds useful as protein kinase inhibitors |
| 04/15/2014 | CA2680819C Novel porphyrazine coloring matter, ink, ink set and colored product |
| 04/10/2014 | WO2014055955A1 Gdf-8 inhibitors |
| 04/10/2014 | WO2014055647A1 (sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases |
| 04/10/2014 | WO2014055548A1 Anti-fibrotic pyridinones |
| 04/10/2014 | WO2014055297A1 Novel urea compounds |
| 04/10/2014 | WO2014054898A1 Novel organic electroluminescent compounds and organic electroluminescent device containing the same |
| 04/10/2014 | WO2014054053A1 Spirocyclic compounds, compositions and medicinal applications thereof |
| 04/10/2014 | WO2014053967A1 Pyrrolo[2,3-d]pyrimidine tropomyosin-related kinase inhibitors |
| 04/10/2014 | WO2014053965A1 Tropomyosin-related kinase inhibitors |
| 04/10/2014 | WO2014053605A1 Coelenterazine analogues emitting a red-shifted light intended for in vivo imaging |
| 04/10/2014 | WO2014053568A1 Indolyldihydroimidazopyrimidinone derivatives, preparation thereof and therapeutic use thereof |
| 04/10/2014 | US20140100373 Production method of imidazole derivatives |
| 04/10/2014 | US20140100364 Compounds Useful For Making HCV Protease Inhibitors |
| 04/10/2014 | US20140100228 Small molecule inhibitors of influenza a rna-dependent rna polymerase |
| 04/10/2014 | US20140100217 Structural mimetics of proline-rich peptides and their use |
| 04/10/2014 | US20140100215 Methods of Using PI3K and MEK Modulators |
| 04/10/2014 | US20140100211 New pyrrolidine derivatives, pharmaceutical compositions and uses thereof |
| 04/10/2014 | US20140099681 Process for producing optically active succinimide derivatives and intermediates thereof |
| 04/09/2014 | EP2716643A1 Pyrrolopyrimidine compounds and their uses |
| 04/09/2014 | EP2716157A1 Imidazopyrazine Syk inhibitors |
| 04/09/2014 | EP2714694A1 Bacteriochlorin imides |
| 04/09/2014 | EP2714693A2 Anti-viral compounds |
| 04/09/2014 | EP2714692A1 Substituted aminoimidazopyridazines |
| 04/09/2014 | EP2714690A1 3-spirocyclic piperidine derivatives as ghrelin receptor agonists |
| 04/09/2014 | EP2714660A1 Neprilysin inhibitors |
| 04/09/2014 | EP2714659A1 Compounds with oxime ester and/or acyl groups |
| 04/09/2014 | EP2714658A1 Novel hybrid cholinesterase inhibitors |
| 04/09/2014 | EP2714047A1 Novel ticagrelor co - crystal |
| 04/09/2014 | CN103717605A Spiro-oxindole mdm2 antagonists |
| 04/09/2014 | CN103717604A Substituted aminoimidazopyridazines |
| 04/09/2014 | CN103717603A Novel compounds for organic electronic material and organic electroluminescent device using the same |
| 04/09/2014 | CN103717602A Kinase inhibitors |
| 04/09/2014 | CN103717599A Indazoles |
| 04/09/2014 | CN103717593A Compositions and methods for modulating a kinase |
| 04/09/2014 | CN103709171A Derivative with pyridazine[3,4-b] indole framework structure and synthesis method thereof |
| 04/09/2014 | CN103709170A Medicinal crude drug for reducing blood sugar |
| 04/09/2014 | CN103709169A Crystallization morphology of 6-(4-chlorophenyl)-2, 2-dimethyl-7-phenyl-2, 3-dihydro-pyrrolizinone-5-acetate nitric acid butyl ester |
| 04/09/2014 | CN103709168A Crystallization morphology of 6-(4-chlorophenyl)-2, 2-dimethyl-7-phenyl-2, 3-dihydro-pyrrolizinone-5-acetate nitric acid butyl ester |
| 04/09/2014 | CN103709167A Novel method used for preparing ticagrelor capable of inhibiting platelet aggregation |
| 04/09/2014 | CN103709122A Antitumor and antifungal compound for treatment |
| 04/09/2014 | CN103709093A Combined-ring-containing pleuromutilin antibiotics |
| 04/09/2014 | CN102675323B Pyrrole-[2, 1-f] [1, 2 and 4] triazine derivative and antitumor effect thereof |
| 04/09/2014 | CN102399226B 3-substituted benzamido-3,4-dihydro-4-imine-5-methylmercapto-7-alkylthio pyrimido [4,5-d] pyrimidine with herbicidal activity and preparation method thereof |
| 04/09/2014 | CN102180880B Method for synthesizing bromophenyl pyrazolo[3,4-d]pyrimidine derivative |
| 04/09/2014 | CN102131812B Pyrrolo[2,3-d]pyrimidine compounds |
| 04/09/2014 | CN101528704B Serine-threonine protein kinase and PARP modulators |
| 04/08/2014 | US8691982 Pyrazolo[1,5-a]-1,3,5-triazine derivatives, preparation thereof, and therapeutic use thereof |
| 04/08/2014 | US8691981 Crystalline forms of (S)-1-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)pyrrolo[1,2-f][1,2,4]triazin-2-yl)-N-(6-fluoropyridin-3-yl)-2-methylpyrrolidine-2-carboxamide |
| 04/08/2014 | US8691864 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof |
| 04/08/2014 | US8691856 Glucagon receptor antagonists, preparation and therapeutic uses |
| 04/08/2014 | US8691827 Amino tetrahydro-pyridopyrimidine PDE10 inhibitors |
| 04/08/2014 | US8691826 Compounds |
| 04/08/2014 | US8691825 Inhibitors of AKT activity |
| 04/08/2014 | US8691819 Alpha helix mimetic compositions for treating cancer and other CBP/catenin-mediated diseases and conditions |
| 04/08/2014 | US8691811 Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof |
| 04/08/2014 | US8691810 Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases |
| 04/08/2014 | US8691807 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors |
| 04/08/2014 | US8691803 Process for the preparation of antibiotic compounds |
| 04/08/2014 | US8691546 Inhibitors of Bruton's tyrosine kinase |
| 04/08/2014 | CA2634553C Triazole derivatives |
| 04/08/2014 | CA2630271C Fused bicyclic mtor inhibitors |
| 04/08/2014 | CA2621443C Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 04/03/2014 | WO2014052828A1 Compositions and methods for modulating tlr4 |
| 04/03/2014 | WO2014052669A1 Modulation of ire1 |
| 04/03/2014 | WO2014050764A1 Photoelectric conversion element, imaging element, optical sensor |
| 04/03/2014 | WO2014050583A1 Infrared-blocking film, infrared-blocking laminated glass, and infrared-blocking member |
| 04/03/2014 | WO2014050417A1 Organic electroluminescent element, lighting device, and display device |
| 04/03/2014 | WO2014048945A1 Bet protein-inhibiting 5-aryl triazole azepines |
| 04/03/2014 | WO2014048894A1 Substituted indazol-pyrrolopyrimidines useful in the treatment of hyperfoliferative disorders |
| 04/03/2014 | WO2014048878A1 Phenyl- or pyridyl- pyrrolo[2,3b]pyrazine derivatives useful in the treatment or prevention of proliferative disorders or dysplasia |
| 04/03/2014 | WO2014048869A1 Substituted indazol-pyrrolopyrimidines useful in the treatment of hyperproliferative diseases |
| 04/03/2014 | WO2014048865A1 New bicyclic derivatives |
| 04/03/2014 | WO2014048165A1 Compound as potassium channel modulator |
| 04/03/2014 | US20140094604 New intermediates and processes for preparing ticagrelor |
| 04/03/2014 | US20140094529 Molecular containers and methods of making and using same |
| 04/03/2014 | US20140094477 Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
| 04/03/2014 | US20140094476 Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
| 04/03/2014 | US20140094474 Androgen receptor modulating carboxamides |
| 04/03/2014 | US20140094468 Pteridines Useful As HCV Inhibitors And Methods For The Preparation Thereof |
| 04/03/2014 | US20140094466 Ssh-2 (slingshot-2) inhibitors and methods for making and using them |
| 04/03/2014 | US20140094459 Tyrosine Kinase Inhibitors |
| 04/03/2014 | US20140094450 Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators |